Abstract
Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for convenient purification by immobilized metal-ion affinity chromatography and labeling with [(99m)Tc(CO)3](+) but increases radioactivity uptake in the liver. To investigate the impact of charge, lipophilicity, and position on biodistribution, 10 variants of a histidine-based tag was attached to a HER2 binding affibody molecule. The biochemical properties and the HER2 binding affinity appeared to be similar for all variants. In vivo, positive charge promoted liver uptake. For N-terminally placed tags, lipophilicity promoted liver uptake and decreased kidney uptake. Kidney uptake was higher for C-terminally placed tags compared to their N-terminal counterparts. The variant with the amino acid composition HEHEHE placed in the N-terminus gave the lowest nonspecific uptake.
Original language | English |
---|---|
Pages (from-to) | 4966-74 |
Journal | Journal of Medicinal Chemistry |
Volume | 56 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2013 Jun 27 |
Externally published | Yes |
Subject classification (UKÄ)
- Biochemistry and Molecular Biology
Free keywords
- Animals
- Cell Line, Tumor
- Drug Stability
- Female
- Histidine
- Humans
- Hydrophobic and Hydrophilic Interactions
- Isotope Labeling
- Kinetics
- Mice
- Organotechnetium Compounds/chemistry
- Receptor, ErbB-2/metabolism
- Recombinant Fusion Proteins/chemistry
- Tissue Distribution